⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30927454 | 1.00 | — | — | |
| SCHEMBL19785439 | 0.75 | — | — | |
| SCHEMBL22532537 | 0.75 | — | — | |
| SCHEMBL19261599 | 0.75 | — | — | |
| SCHEMBL13089936 | 0.75 | — | — | |
| SCHEMBL6027802 | 0.75 | — | — | |
| SCHEMBL20840676 | 0.70 | — | — | |
| SCHEMBL19124369 | 0.69 | GOT1 (0.35) | — | |
| SCHEMBL913739 | 0.68 | — | — | |
| SCHEMBL12902021 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2396337-B1 | PREPARATION AND USE OF ZINC-AMIDES | UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) | 2016-07-13 | — | — | EP | claimed |
| CN-102395593-B | Preparation and use of zinc amides | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2015-08-12 | — | — | CN | claimed |
| EP-2396337-A1 | PRODUCTION AND USE OF ZINC AMIDES | Ludwig-Maximilians-Universität München (DE) | 2011-12-21 | — | — | EP | claimed |
| US-20110288296-A1 | PRODUCTION AND USE OF ZINC AMIDES | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2011-11-24 | — | — | US | claimed |
| WO-2010092096-A1 | PRODUCTION AND USE OF ZINC AMIDES | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2010-08-19 | — | — | WO | claimed |
| US-12527325-B2 | Pesticidally active diazine-amide compounds | SYNGENTA CROP PROTECTION AG (CH) | 2026-01-20 | — | — | US | disclosed |
| WO-2025111408-A1 | COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY AND HUNTINGTON'S DISEASE | BIOGEN MA INC. (US) | 2025-05-30 | — | — | WO | disclosed |
| US-20250084064-A1 | 2-AMINO-N-HETEROARYL-NICOTINAMIDES AS NAV1.8 INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2025-03-13 | — | — | US | disclosed |
| WO-2025051214-A1 | AROMATIC HETEROCYCLIC COMPOUND AND PREPARATION METHOD THEREFOR | 上海翊石医药科技有限公司 | 2025-03-13 | — | — | WO | disclosed |
| US-12195445-B2 | 2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors | MERCK SHARP & DOHME LLC (US) | 2025-01-14 | — | — | US | disclosed |
| CN-113272293-B | 2-Amino-N-heteroaryl-nicotinamide as NAV1.8 inhibitor | 默沙东有限责任公司 | 2024-06-14 | — | — | CN | disclosed |
| WO-2023205173-A1 | SUBSTITUTED PIPERIDINES AND SUBSTITUTED TETRAHYDROPYRIDINES AS IMMUNE-MODULATING COMPOUNDS | BLACKSMITH MEDICINES, INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| US-20110288296-A1 | PRODUCTION AND USE OF ZINC AMIDES | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2011-11-24 | — | — | US | disclosed |
| US-20110288296-A1 | PRODUCTION AND USE OF ZINC AMIDES | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2011-11-24 | — | — | US | disclosed |
| US-20110288296-A1 | PRODUCTION AND USE OF ZINC AMIDES | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2011-11-24 | — | — | US | disclosed |
| WO-2010092096-A1 | PRODUCTION AND USE OF ZINC AMIDES | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2010-08-19 | — | — | WO | disclosed |
| WO-2010092096-A1 | PRODUCTION AND USE OF ZINC AMIDES | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2010-08-19 | — | — | WO | disclosed |
| US-20100204230-A1 | PIPERAZINE DERIVATIVES FOR TREATMENT OF AD AND RELATED CONDITIONS | MERCK SHARP & DOHME CORP. | 2010-08-12 | — | — | US | disclosed |
| EP-2121633-A2 | PIPERAZINE DERIVATIVES FOR TREATMENT OF AD AND RELATED CONDITIONS | Merck & Co., Inc. (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008099210-A2 | PIPERAZINE DERIVATIVES FOR TREATMENT OF AD AND RELATED CONDITIONS | MERCK & CO., INC. (US) | 2008-08-21 | — | — | WO | disclosed |